Margo R. Roberts, Chief Scientific Officer at Kite Pharma, Inc. (KITE), sold 6,145 shares at $64.66 ($395K) on 2015-09-15, disclosed to the SEC on 2015-09-17.
Scheduled sale ($395k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.98 | 2,964 | $190K | 48.0% |
| 2 | $64.66 | 3,181 | $206K | 52.0% |
| Total | $64.33 avg | 6,145 | $395K | 100% |
| Filing → |
| KITE | SELL | 2016-02-16 | $1.2M | — | Filing → |
| KITE | SELL | 2016-01-19 | $339K | — | Filing → |
| KITE | SELL | 2015-12-17 | $392K | — | Filing → |